Igenomix India +91 11 6651 7800 info.india@igenomix.com

Blog

Knowing your genes is crucial. You might not be aware of the genetic information you are carrying but you could possibly be a carrier of a genetic disorder as everyone […]

Read more

Save The Date. 15th September to 17th September at International Convention Centre, Hyderabad, India IGENOMIX India will be taking part in the 6th International Congress of Academy of Clinical Embryologists […]

Read more

Every couple have plenty of questions in their minds before planning for a baby and one among them is the risk of passing the genetic disorder to their to be […]

Read more

In women over 38 years old, 79% of embryos have chromosomal abnormalities, which is a major reason for recurrent miscarriages or IVF failures. The risk of abnormalities grows as the […]

Read more

When trying to conceive, both the embryo and the uterus are critical to implantation and pregnancy. For implantation to be successful, and the lining of the uterus (endometrium) and the […]

Read more
3 July, 2017

Vacancy: Laboratory Technician Profile: Qualification: Graduate or Post Graduate in life sciences Experience: Minimum 1-2 years’ working experience in Molecular biology laboratory Required: Practical and theoretical knowledge of general molecular […]

Read more
26 June, 2017 ,

We are proud to announce our wide participation at this year ESHRE annual meeting in Geneva, Switzerland from July 2nd – July 5th, 2017. Find out the full program here.

Read more

This year’s Human Reproduction keynote lecture, which will open ESHRE’s Annual Meeting in Geneva, will be given by our CSO Prof. Carlos Simón, who will address one of the biggest audiences […]

Read more

IGENOMIX at ESHRE 2017 From 2 – 5 July at Palexpo venue, Geneva, Switzerland. IGENOMIX will be taking part in this year’s ESHRE Annual Meeting, held at the Palexpo venue […]

Read more

We are proud to announce that our product autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells (IGX1) was granted the Orphan Drug Designation (ODD) on March 15th 2017 by […]

Read more